Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phosphodiesterase 9A as prostate cancer marker

Phosphodiesterase 9A as prostate cancer marker

US Patent 9828604 · Granted Nov 28, 2017

Estimated economic value: $1,502,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Post-surgical risk stratification based on PDE4D variant expression, selected ac2025
Method and system for secure and automatic mapping of blockchain-based ledgers t2025
Evaluating input data using a deep learning algorithm2025
Pre-surgical risk stratification based on PDE4D7 and DHX9 expression2025
Dynamic rerouting of uniform resource identifiers having different syntaxes2024
Pre-surgical risk stratification based on PDE4D7 expression and pre-surgical cli2024
Evaluating input data using a deep learning algorithm2023
Methods of prostate cancer prognosis2023
Subject clustering method and apparatus2023
Relay2022
Assessment of cellular signaling pathway activity using probabilistic modeling o2022
Method for monitoring an electromechanical component of an automated system2022